Potential of combined simvastatin and metformin as a low-toxicity therapy alternative to docetaxel for preserving redox homeostasis in triple-negative breast cancer
Potential of combined simvastatin and metformin as a low-toxicity therapy alternative to docetaxel for preserving redox homeostasis in triple-negative breast cancer. // Medical Hypotheses. – URL: https://www.sciencedirect.com/science/article/pii/S0306987726003804?dgcid=rss_sd_all
Potential of combined simvastatin and metformin as a low-toxicity therapy alternative to docetaxel for preserving redox homeostasis in triple-negative breast cancer. Medical Hypotheses. https://www.sciencedirect.com/science/article/pii/S0306987726003804?dgcid=rss_sd_all
“Potential of combined simvastatin and metformin as a low-toxicity therapy alternative to docetaxel for preserving redox homeostasis in triple-negative breast cancer.” Medical Hypotheses.
@article{article108228,
title = {Potential of combined simvastatin and metformin as a low-toxicity therapy alternative to docetaxel for preserving redox homeostasis in triple-negative breast cancer},
journal = {Medical Hypotheses},
url = {https://www.sciencedirect.com/science/article/pii/S0306987726003804?dgcid=rss_sd_all}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...